ClinicalTrials.gov
ClinicalTrials.gov Menu

GTS21-201 for Alzheimer Disease:GTS-21 Administered Daily for 28 Days to Participants With Probable Alzheimer’s Disease

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00414622
Recruitment Status : Completed
First Posted : December 21, 2006
Last Update Posted : April 19, 2007
Sponsor:
Information provided by:
CoMentis

Results Submitted - Not Posted on ClinicalTrials.gov
Results information has been submitted to ClinicalTrials.gov by the sponsor or investigator, but is not yet publicly available (or "posted") on ClinicalTrials.gov. The submitted information may not be available if it is pending Quality Control (QC) Review by the National Library of Medicine (NLM) or if issues identified during QC review are being addressed or corrected by the sponsor or investigator. NLM's limited QC review assesses for apparent errors, deficiencies, or inconsistencies. NLM staff do not verify the scientific validity or relevance of the submitted information.
  Recruitment Status : Completed
  Primary Completion Date : No date given
  Actual Study Completion Date : April 2007

Submission Cycle Results Submitted to ClinicalTrials.gov Results Returned after Quality Control Review
1 August 16, 2010
September 9, 2010